Abdullah Alsrhani

1.4k total citations · 1 hit paper
43 papers, 838 citations indexed

About

Abdullah Alsrhani is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Abdullah Alsrhani has authored 43 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Abdullah Alsrhani's work include COVID-19 Clinical Research Studies (5 papers), MicroRNA in disease regulation (4 papers) and Epigenetics and DNA Methylation (4 papers). Abdullah Alsrhani is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), MicroRNA in disease regulation (4 papers) and Epigenetics and DNA Methylation (4 papers). Abdullah Alsrhani collaborates with scholars based in Saudi Arabia, Malaysia and India. Abdullah Alsrhani's co-authors include Hasan Ejaz, Kashaf Junaid, Sonia Younas, Abualgasim Elgaili Abdalla, Khalid Omer Abdalla Abosalif, Aizza Zafar, Humera Javed, Zeeshan Ahmed, Aisha Farhana and Muhammad Ikram Ullah and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Abdullah Alsrhani

37 papers receiving 810 citations

Hit Papers

COVID-19 and comorbidities: Deleterious impact on infecte... 2020 2026 2022 2024 2020 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdullah Alsrhani Saudi Arabia 9 391 197 135 109 76 43 838
Khalid Omer Abdalla Abosalif Saudi Arabia 12 438 1.1× 196 1.0× 119 0.9× 133 1.2× 76 1.0× 27 965
Roberto Parrella Italy 14 373 1.0× 198 1.0× 98 0.7× 111 1.0× 55 0.7× 51 826
Haoran Yang China 12 649 1.7× 371 1.9× 167 1.2× 143 1.3× 71 0.9× 27 1.1k
Jae Young Moon South Korea 15 311 0.8× 138 0.7× 177 1.3× 199 1.8× 29 0.4× 75 1.1k
Sajad Yaghoubi Iran 16 409 1.0× 209 1.1× 275 2.0× 212 1.9× 64 0.8× 37 1.2k
Chengzhi Wang China 12 243 0.6× 112 0.6× 109 0.8× 205 1.9× 76 1.0× 27 815
Francesco Ferrara Italy 21 647 1.7× 203 1.0× 84 0.6× 242 2.2× 43 0.6× 102 1.3k
Siddhartha Dutta India 16 438 1.1× 116 0.6× 58 0.4× 147 1.3× 110 1.4× 74 1.0k
Yiyin Chen China 15 360 0.9× 188 1.0× 209 1.5× 297 2.7× 99 1.3× 30 1.3k
Tielong Chen China 13 613 1.6× 339 1.7× 183 1.4× 149 1.4× 77 1.0× 43 1.1k

Countries citing papers authored by Abdullah Alsrhani

Since Specialization
Citations

This map shows the geographic impact of Abdullah Alsrhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Alsrhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Alsrhani more than expected).

Fields of papers citing papers by Abdullah Alsrhani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah Alsrhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Alsrhani. The network helps show where Abdullah Alsrhani may publish in the future.

Co-authorship network of co-authors of Abdullah Alsrhani

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah Alsrhani. A scholar is included among the top collaborators of Abdullah Alsrhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah Alsrhani. Abdullah Alsrhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alsrhani, Abdullah, Muhammad Atif, & Aisha Farhana. (2025). Distinct Circulating Biomarker Profiles Associated with Type 2 Diabetes in a Regional Cohort—A Cross-Sectional Study. Metabolites. 15(12). 776–776.
2.
Khan, Yusuf S., Aisha Farhana, Mohammed Kuddus, et al.. (2025). MicroRNA-125b-5p Drives MMP-2 Expression via Activation of RAGE-38MAPK-p65/p50NF-κB Axis: A Novel Mechanism in Human Lung Cancer Cells. International Journal of Molecular Sciences. 26(20). 9983–9983.
5.
Mohamed, Magdi Awadalla, Tilal Elsaman, Abozer Y. Elderdery, et al.. (2024). Unveiling the Anticancer Potential: Computational Exploration of Nitrogenated Derivatives of (+)-Pancratistatin as Topoisomerase I Inhibitors. International Journal of Molecular Sciences. 25(19). 10779–10779. 4 indexed citations
6.
Atif, Muhammad, Abdullah Alsrhani, Farrah Naz, et al.. (2024). Adenosine A2AR in viral immune evasion and therapy: unveiling new avenues for treating COVID-19 and AIDS. Molecular Biology Reports. 51(1). 894–894. 1 indexed citations
7.
8.
Alzahrani, Badr, Abozer Y. Elderdery, Abdullah Alsrhani, et al.. (2023). Effects of Albumin–Chlorogenic Acid Nanoparticles on Apoptosis and PI3K/Akt/mTOR Pathway Inhibitory Activity in MDA-MB-435s Cells. Nanomaterials. 13(9). 1438–1438. 6 indexed citations
9.
Farhana, Aisha, Abdullah Alsrhani, Yusuf S. Khan, & Zafar Rasheed. (2023). Cancer Bioenergetics and Tumor Microenvironments—Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems. Cancers. 15(15). 3836–3836. 17 indexed citations
10.
Farhana, Aisha, Abdullah Alsrhani, Nazia Nazam, et al.. (2023). Gold Nanoparticles Inhibit PMA-Induced MMP-9 Expression via microRNA-204-5p Upregulation and Deactivation of NF-κBp65 in Breast Cancer Cells. Biology. 12(6). 777–777. 9 indexed citations
11.
Alsrhani, Abdullah, Abozer Y. Elderdery, Badr Alzahrani, et al.. (2023). Therapeutic Potential of Albumin Nanoparticles Encapsulated Visnagin in MDA-MB-468 Triple-Negative Breast Cancer Cells. Molecules. 28(7). 3228–3228. 5 indexed citations
12.
Alzahrani, Badr, Abozer Y. Elderdery, Nasser A. N. Alzerwi, et al.. (2023). Pluronic-F-127-Passivated SnO2 Nanoparticles Derived by Using Polygonum cuspidatum Root Extract: Synthesis, Characterization, and Anticancer Properties. Plants. 12(9). 1760–1760. 8 indexed citations
13.
Elderdery, Abozer Y., Nasser A. N. Alzerwi, Badr Alzahrani, et al.. (2023). Nanocomposites of iron oxide, sodium alginate, and eugenol induce apoptosis via PI3K/Akt/mTOR signaling in Hep3 cells and in vivo hepatotoxicity in the zebrafish model. International Journal of Biological Macromolecules. 256(Pt 2). 127490–127490. 8 indexed citations
14.
15.
Farhana, Aisha, Jenifer Selvarani A, Antony V. Samrot, et al.. (2022). Utilization of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Impregnated Activated Carbon for Removal of Hexavalent Chromium. Journal of Nanomaterials. 2022(1). 15 indexed citations
16.
Elderdery, Abozer Y., et al.. (2022). Molecular Analysis of Xmn1-Polymorphic Site ´5 to Gγ of the β-Globin Gene Cluster in a Saudi Population of Jazan Region in Correlation with Hb F Expression. Evidence-based Complementary and Alternative Medicine. 2022. 1–6.
17.
Atif, Muhammad, Abdullah Alsrhani, Farrah Naz, et al.. (2021). Targeting Adenosine Receptors in Neurological Diseases. Cellular Reprogramming. 23(2). 57–72. 14 indexed citations
18.
Junaid, Kashaf, Hasan Ejaz, Abdullah Alsrhani, et al.. (2021). Association of IL28 B and IL10 Polymorphism with HCV Infection and Direct Antiviral Treatment.. PubMed. 51(4). 512–520. 5 indexed citations
19.
Ejaz, Hasan, Sonia Younas, Khalid Omer Abdalla Abosalif, et al.. (2021). Molecular analysis of blaSHV, blaTEM, and blaCTX-M in extended-spectrum β-lactamase producing Enterobacteriaceae recovered from fecal specimens of animals. PLoS ONE. 16(1). e0245126–e0245126. 55 indexed citations
20.
Ullah, Muhammad Ikram, et al.. (2021). Determination of serum tumor necrosis factor-alpha (TNF-α) levels in metabolic syndrome patients from Saudi population. Pakistan Journal of Medical Sciences. 37(3). 700–705. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026